Abstract 3885: A secondary Gαq mutation confers resistance to Gαq inhibitors in uveal melanoma

作者
Jiafang Ma,Meng Wang,Aashish Manglik,Boris C. Bastian,Xu Chen
出处
期刊:Cancer Research [American Association for Cancer Research]
卷期号:83 (7_Supplement): 3885-3885
标识
DOI:10.1158/1538-7445.am2023-3885
摘要

Abstract Uveal melanoma (UM) is a rare subtype of melanoma that originates from melanocytes of the choroidal plexus, ciliary body and iris. Despite successful treatment of the primary by radiation or surgery, 50% of UM patients develop metastases, mostly in the liver, as an invariably lethal complication. Over 90% of UM harbor activating mutations in the closely related GNAQ or GNA11 genes, mainly at codons Q209, compromising the GTPase activity. Mutant GNAQ and GNA11 can be successfully targeted by the cyclic depsipeptide YM-254890. To anticipate mechanisms of resistance that might arise under treatment with this novel class of Gαq inhibitors, we generated UM cell lines resistant to YM-254890 using an in-vitro cell culture system. Upon chronic growth suppression of a GNA11Q209L mutant UM cell line, we established 12 YM-254890 resistance clones. We identified a secondary GNA11F75Y mutation in one clone and GNA11Y192H mutations in the other 11 clones. The secondary mutations were present in cis with the original GNA11 Q209L mutations. To validate the functional role of these secondary mutations in conveying resistance, we engineered two double mutants, GNA11Q209L/F75Y and GNA11Q209L/Y192H, and introduced them into 293FT cells respectively and confirmed that both F75Y and Y192H convey resistance to YM-254890 treatment. The proliferation of YM-254890-resistant cell lines was still dependent on GNA11 and downstream PKC/MAPK signaling. Combined inhibition of PKC and MEK synergistically reduced cell viability in YM-254890 resistant UM cells. Analysis of the crystal structure of YM-2548890 in complex with GNAQ predicts both F75Y and Y192H mutations directly affect the binding of YM-254890 to Gαq. Our data suggest that direct targeting mutant GNAQ/11 is promising but will select for secondary mutations within GNAQ/11 that will result in resistance. Combinatorial targeting of other components in the Gαq signaling pathway will increase clinical efficacy. Citation Format: Jiafang Ma, Meng Wang, Aashish Manglik, Boris C. Bastian, Xu Chen. A secondary Gαq mutation confers resistance to Gαq inhibitors in uveal melanoma. [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 1 (Regular and Invited Abstracts); 2023 Apr 14-19; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2023;83(7_Suppl):Abstract nr 3885.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
方圆完成签到 ,获得积分10
1秒前
1秒前
遇见完成签到,获得积分20
2秒前
2秒前
2275523154完成签到,获得积分10
2秒前
千里清秋完成签到,获得积分10
2秒前
quan完成签到,获得积分10
2秒前
美宁完成签到,获得积分10
4秒前
顺利的妖妖完成签到 ,获得积分10
5秒前
再睡十分钟完成签到 ,获得积分10
5秒前
penicillin完成签到 ,获得积分10
5秒前
辛勤以柳发布了新的文献求助10
7秒前
敏感的傲云完成签到,获得积分10
7秒前
7秒前
xiahaijun发布了新的文献求助10
8秒前
8秒前
情怀的应助被七听采纳,获得10
9秒前
李明明完成签到,获得积分10
9秒前
10秒前
微血管完成签到,获得积分10
10秒前
yyy完成签到,获得积分10
10秒前
大胆的初瑶完成签到,获得积分10
10秒前
以后完成签到,获得积分10
11秒前
11秒前
虚幻沛文完成签到 ,获得积分10
12秒前
灵感大王发布了新的文献求助10
12秒前
缥缈凡旋完成签到,获得积分10
12秒前
上官若男的应助被米晓雪采纳,获得30
13秒前
11完成签到,获得积分10
14秒前
灵感大王发布了新的文献求助10
15秒前
灵感大王发布了新的文献求助10
15秒前
英姑的应助被光亮向真采纳,获得10
15秒前
灵感大王发布了新的文献求助30
15秒前
YY完成签到,获得积分10
15秒前
灵感大王发布了新的文献求助10
16秒前
灵感大王发布了新的文献求助10
16秒前
欢呼的兰完成签到,获得积分10
17秒前
在水一方的应助被缺粥采纳,获得10
17秒前
英俊的铭的应助被七听采纳,获得10
18秒前
18秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8190478
求助须知:如何正确求助?哪些是违规求助? 9577686
关于积分的说明 21853808
捐赠科研通 7789496
什么是DOI,文献DOI怎么找? 3436407
关于科研通互助平台的介绍 2560235
邀请新用户注册赠送积分活动 2483054